SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare informs about dividend payment

25 May 2018 Evaluate

Cadila Healthcare has informed that the Company shall make the payment of dividend of Rs 3.50 (350%) on 102,37,42,600 Equity Shares of Re 1 each on or after August 18, 2018 subject to the approval of the same by the shareholders at the ensuing 23rd Annual General Meeting scheduled to be held on August 13, 2018.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

928.85 -7.50 (-0.80%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×